Benlysta IV infusion 400mg, manufactured by GlaxoSmithKline, contains Belimumab (genetical recombination) (YJ code: 3999445D2027, 400mg 1 bottle). It is a BLyS-specific inhibitor used for active systemic lupus erythematosus (SLE) and active lupus nephritis in adults.
Benlysta IV infusion 400mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).